Our Partners

In-licensing Interests

Drug Delivery Technologies

Osmotica has an active program to in-license technology to expand the range of our drug delivery solutions. We believe that our successful commercial track record demonstrates our ability to optimize commercial applications for such technologies.

Drug Compounds for Development

Osmotica is seeking to in-license compounds in all stages of development that address Parkinson's disease or related neurological disorders to compliment our existing R&D pipeline. Osmotica has a track record of successful partnerships, co-development programs and strategic collaborations.

Contact us to discuss in-licensing opportunities